title: Canadian Association of Gastroenterology position statement: hip fracture and proton pump inhibitor therapy-a 2013 update.
authors.forename: Paul
authors.initials: P
authors.lastname: Moayyedi
authors.forename: Yuhong
authors.initials: Y
authors.lastname: Yuan
authors.forename: Grigorios
authors.initials: G
authors.lastname: Leontiadis
mesh_terms: D002170:Canada; D005762:Gastroenterology / Q000458:organization & administration*; D006620:Hip Fractures / Q000139:chemically induced*; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced*; D017410:Practice Guidelines as Topic; D054328:Proton Pump Inhibitors / Q000009:adverse effects*; D018570:Risk Assessment; D012307:Risk Factors; D012955:Societies, Medical / Q000458:organization & administration*
chemical_list: D054328:Proton Pump Inhibitors